Analysis Conduced | Matched Population Sizes | Mortality Events (n) | Median Survival Time (days) | Hazard Ratio, (95% CI) | P-value | |||
---|---|---|---|---|---|---|---|---|
Group 1 | Group 2 | Group 1 | Group 2 | Group 1 | Group 2 | |||
Myocarditis | Non- myocarditis | 424 | 204 | 185 | 323 | Majority alive | 1.26, (1.04- 1.54) | 0.02 |
Pericarditis | Non- pericarditis | 192 | 101 | 85 | 249 | Majority alive | 1.36, (1.02- 1.81) | 0.04 |
Tamponade | Non- tamponade | 415 | 288 | 204 | 84 | 324 | 2.15, (1.79- 2.57) | < 0.01 |
Pericardial effusion | Non- pericardial effusion | 3,756 | 1,928 | 1,542 | 266 | Majority alive | 1.49, (1.39- 1.59) | < 0.01 |
Pericarditis Disease | Non- pericardial disease | 3,945 | 2,027 | 1,659 | 263 | Majority alive | 1.46, (1.37- 1.56) | < 0.001 |
Myocarditis | Pericarditis | 144 | 69 | 75 | 267 | 249 | 0.97, (0.70- 1.35) | 0.87 |
Myocarditis | Pericardial Disease | 376 | 184 | 191 | 289 | 251 | 0.95, (0.77- 1.16) | 0.60 |